Why COVID-19 patients have more pathogenic bacteria in their noses

Why COVID-19 patients have more pathogenic bacteria in their noses

In a new study published on the bioRxiv* preprint server, researchers from the University of California Irvine investigated the effect of SARS-CoV-2 infection on the nasal microbiome. The team of researchers used 16S ribosomal ribonucleic acid (rRNA) gene amplicon sequencing to determine whether SARS-CoV-2 infection led to a change in the composition of the nasal microbiome.